2mon
GlobalData on MSNLantheus acquires radiopharma CDMO Evergreen for up to $1bnGlobalData is the parent company of Pharmaceutical Technology. "Lantheus acquires radiopharma CDMO Evergreen for up to $1bn" ...
Through the transaction, Lantheus has acquired OCTEVY™, a registrational-stage PET diagnostic imaging agent targeting neuroendocrine tumors, which complements Lantheus’ therapeutic candidate PNT2003, ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Certara (CERT – Research Report), Lantheus ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results